IP Library Granted Patent US 9,139,588
Granted Patent B2
US 9,139,588 · App. 13/515,114 · Granted Sep 22, 2015

Method for late introduction of the (

Inventors: Craig Arthur Townsend (Baltimore, MD); Micah Jeffrey Bodner (Dexter, OR); Ryan Martin Phelan (Baltimore, MD); Michael Francis Freeman (Baltimore, MD)
Assignee: THE JOHNS HOPKINS UNIVERSITY
C07D477/20C12P17/184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,139,588
App. No.
13/515,114
Granted
Sep 22, 2015
Kind
B2
Abstract

The presently disclosed subject matter demonstrates that ThnG and ThnQ enzymes encoded by the thienamycin gene cluster in Streptomyces cattleya oxidize the C-2 and C-6 moieties of carbapenems, respectively. ThnQ stereospecifically hydroxylates PS-5 giving N-acetyl thienamycin. ThnG catalyzes sequential desaturation and sulfoxidation of PS-5, giving PS-7 and its sulfoxide. The ThnG and ThnQ enzymes are relatively substrate selective, but give rise to the oxidative diversity of carbapenems produced by S. cattleya , and orthologues likely function similarly in allied streptomyces.

Claims (9)

1. A process for preparing a carbapenem of Formula (I):

the process comprising contacting or incubating a carbapenem substrate of Formula (Ia):

with a purified ThnQ enzyme that stereospecifically hydroxylates the C8 carbon atom of the carbapenem substrate of Formula (Ia) under reaction conditions to produce an optically-pure carbapenem of Formula (I);

wherein:

R 1 is H;

R 2 is selected from the group consisting of —SCH 2 CH 2 NH 2 , —SCH═CHNHC(═O)CH 3 , —S-pantethienyl, —SCH 2 CH 2 NHC(═O)R′, wherein R′ is C 1 -C 10 substituted or unsubstituted linear or branched alkyl, which can be further substituted with one or more 3-6 member cycloalkyl rings, or aminoalkyl; and

R 3 is H.

2. The process of claim 1 , wherein R 2 is —SCH 2 CH 2 NHC(═O)R′, and wherein the —C(═O)R′ moiety is selected from the group consisting of glycyl, β-alanyl, 2-hydroxyacetyl, 2-methoxyacetyl, 3-hydroxypropionyl, 4-hydroxybutanoyl, and 3,4-dihydroxybutanoyl.

3. The process of claim 1 , wherein the compound of Formula (I) is selected from the group consisting of:

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 27, 2016
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039172/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2012
From: TOWNSEND, CRAIG ARTHUR; BODNER, MICAH JEFFREY; PHELAN, RYAN MARTIN; FREEMAN, MICHAEL FRANCIS
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 029434/0763 →
Continuity (2)
Provisional Application 61285608 · Dec 11, 2009
Related Publication 20130066066A1 · Mar 14, 2013